
Global Diabetic Foot Ulcers Treatment Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2028
13184
May 2023
168
“Global Diabetic Foot Ulcers Treatment Market Analysis Trends, Applications, Analysis, Growth, and Forecast to 2028” is a recent report generated by MarketResearch.biz. The global diabetic foot ulcers treatment market report has been segmented on the basis of treatment, ulcer type, and region.
Global Diabetic Foot Ulcers Treatment Market: Overview
A diabetic foot ulcer is a common situation in diabetic patients, and can be a disabling condition, including resulting in amputation of the leg. The main reason for diabetic foot ulcer is neuropathic and vascular changes in diabetes patients, which result in chronic wounds owing to minor trauma or pressure. The mortality rate is high because of diabetic foot ulcers, and chances of reappearance of cured foot ulcers is relatively high. Wound management treatment is necessary for diabetic foot ulcers, and this condition is resulting in high demand for suitable treatment.
Global Diabetic Foot Ulcers Treatment Market: Dynamics
Among the other primary factors projected to drive growth of the global diabetic foot ulcers treatment market are increasing prevalence of chronic diabetes, rising awareness to treat these conditions and wounds, and growing demand for significant and effective medication and treatment. Technological improvements and advancements in the treatment of diabetic foot ulcers and introduction of numerous novel wound healing agents that are administrated as sprays or ointment, or injected directly into the wound is projected to boost market growth.
However, high cost of ulcer treatment is a major factor projected to hamper growth of the global diabetic foot ulcer treatment market. In addition, lack of trained personnel for this treatment in remote and underdeveloped economies is expected to act as a restraint to demand.
Moreover, enhancement of numerous devices such as shock waves for diabetic foot ulcers treatment is projected to create major growth opportunities for players operating in the global diabetic foot ulcers treatment market in future.
Global Diabetic Foot Ulcers Treatment Market: Segment Analysis
Among the treatment segments, the wound care dressing segment is expected to dominate is terms of revenue share, and is projected to register a significant growth rate.
Among the ulcer type segments, the neuro-Ischemic ulcer type segment is expected to account highest revenue share and is projected to register the fastest growth rate as compared to other ulcer type segments.
Global Diabetic Foot Ulcers Treatment Market: Region Analysis
North America market is expected to dominate with highest revenue share as compared to markets in other regions over the forecast period. This is attributed to increasing geriatric population, and large patient pool of diabetic patients and well established healthcare facilities and infrastructure in countries in the region. In addition, extended research and development and approval cycles are required owing to capital-intensive nature in countries of North America, and this is among some of the major factors projected to drive growth of the market in the region. However, rising adoption of novel biologics and wound care devices for treatment of these ulcers are contributing to the dominance of the market in North America.
The market in Europe is projected to account for second major share contribution to the global market, followed by Asia Pacific. Asia Pacific diabetic foot ulcers treatment market is expected to register a significant compounded annual growth rate in the near future. This can be attributed to growing prevalence of chronic diabetes in developing countries such as China and India. Rising adoption and favorable government legislation in developed economies such as Australia and Japan is also expected to drive overall market growth in this region.
Global Diabetic Foot Ulcers Treatment Market Segmentation:
Segmentation by Treatment:
- Biologics
- Wound care dressings
- Therapy devices
Segmentation by Ulcer Type:
- Neuropathic
- Ischemic
- Neuro-ischemic ulcers
Segmentation by Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- M Healthcare
- Smith & Nephew Plc.
- Molnlycke Health Care AB
- Medtronic Plc
- ConvaTec, Inc.
- Braun Melsungen AG
- Organogenesis, Inc.
- Acelity L.P. Inc.
- Medline Industries, Inc.
- Coloplast A/S
- BSN Medical GMBH
Request for TOC
Inquiry Form
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
OUR CLIENTS
Don't just take our word. We are trusted by these great companies!